Abstract
A defined number of skeletal muscle fibers are formed in two separate waves during prenatal development, while postnatal growth is restricted to hypertrophic muscle fiber growth. The genes of the MRF (muscle regulatory factors) gene family, consisting of 4 structurally related transcription factors - myogenin, MyoD1, myf-5, and MRF4 - regulate both skeletal muscle fiber development and postnatal hypertrophic growth. In meat producing animals, skeletal muscle tissue becomes meat after slaughtering. Skeletal muscle fibers are the major cell type of meat mass. Thus, differences in the activity of the MRF gene family may be very important for the amount of meat deposited in these animals, which is of major economic importance. Therefore, the MRF genes can be considered as potential candidate genes to investigate the relation between genomic variation in these genes and skeletal muscle mass, and thus meat mass. In this review we discuss the MRF gene family in relation to meat production, and show that information of genomic variation in these functional genes, and variation in their expression provide information that can be used in commercial breeding. Furthermore, we will review experiments that show that hormones, growth factors, and specific drugs can affect the expression of these genes, thus potentially affecting skeletal muscle mass and thus meat mass, offering several potential strategies for steering of meat production, and showing the power of functional genomics. Using the genetic information available from these experiments, ways to speed up genetic improvement of livestock breeding and future research directions will be highlighted.
Keywords: skeletal muscle fibers, mrf muscle regulatory factors, Knock out, Myogenin, myf, MyoD, Mrf
Current Genomics
Title: Improvement of Livestock Breeding Strategies Using Physiologic and Functional Genomic Information of the Muscle Regulatory Factors Gene Family for Skeletal Muscle Development
Volume: 2 Issue: 3
Author(s): M. F.W. Te Pas and A. Soumillion
Affiliation:
Keywords: skeletal muscle fibers, mrf muscle regulatory factors, Knock out, Myogenin, myf, MyoD, Mrf
Abstract: A defined number of skeletal muscle fibers are formed in two separate waves during prenatal development, while postnatal growth is restricted to hypertrophic muscle fiber growth. The genes of the MRF (muscle regulatory factors) gene family, consisting of 4 structurally related transcription factors - myogenin, MyoD1, myf-5, and MRF4 - regulate both skeletal muscle fiber development and postnatal hypertrophic growth. In meat producing animals, skeletal muscle tissue becomes meat after slaughtering. Skeletal muscle fibers are the major cell type of meat mass. Thus, differences in the activity of the MRF gene family may be very important for the amount of meat deposited in these animals, which is of major economic importance. Therefore, the MRF genes can be considered as potential candidate genes to investigate the relation between genomic variation in these genes and skeletal muscle mass, and thus meat mass. In this review we discuss the MRF gene family in relation to meat production, and show that information of genomic variation in these functional genes, and variation in their expression provide information that can be used in commercial breeding. Furthermore, we will review experiments that show that hormones, growth factors, and specific drugs can affect the expression of these genes, thus potentially affecting skeletal muscle mass and thus meat mass, offering several potential strategies for steering of meat production, and showing the power of functional genomics. Using the genetic information available from these experiments, ways to speed up genetic improvement of livestock breeding and future research directions will be highlighted.
Export Options
About this article
Cite this article as:
Te Pas F.W. M. and Soumillion A., Improvement of Livestock Breeding Strategies Using Physiologic and Functional Genomic Information of the Muscle Regulatory Factors Gene Family for Skeletal Muscle Development, Current Genomics 2001; 2 (3) . https://dx.doi.org/10.2174/1389202013350788
DOI https://dx.doi.org/10.2174/1389202013350788 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dendritic Cell Vaccine and Cancer Treatment: New Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
Current Pharmaceutical Design Cyclodextrins in Nitrosation Chemistry: New Insights of the NO-Transfer Processes
Mini-Reviews in Organic Chemistry Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease
Current Drug Targets Gender Disparities on Access to Care and Coronary Disease Management
Current Pharmaceutical Design Protein Misfolding in Conformational Disorders: Rescue of Folding Defects and Chemical Chaperoning
Mini-Reviews in Medicinal Chemistry Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications
Current Vascular Pharmacology Role of Ghrelin in Drug Abuse and Reward-Relevant Behaviors: A Burgeoning Field and Gaps in the Literature
Current Drug Abuse Reviews Evaluation of Thiol/Disulfide Homeostasis in Pediatric Patients with Diabetic Ketoacidosis
Combinatorial Chemistry & High Throughput Screening Psychobiome Feeding Mind: Polyphenolics in Depression and Anxiety
Current Topics in Medicinal Chemistry Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE)
Current Vascular Pharmacology Using Naïve Bayes Algorithm to Estimate the Response to Drug in Lung Cancer Patients
Combinatorial Chemistry & High Throughput Screening Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression
Current Enzyme Inhibition Manipulation of Signal Transduction by Botulinum Neurotoxins and their Derivatives
Current Signal Transduction Therapy New Therapeutic Strategy for Mood Disorders
Current Medicinal Chemistry Diabetic Cognitive Dysfunction: From Bench to Clinic
Current Medicinal Chemistry WNT4 Signaling in Female Gonadal Development
Endocrine, Metabolic & Immune Disorders - Drug Targets The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Current Genomics Thrombin-Activatable Fibrinolysis Inhibitor
Current Medicinal Chemistry The Brain, the Penis and Steroid Hormones: Clinical Correlates with Endothelial Dysfunction
Current Pharmaceutical Design